Adagio Medical gets FDA approval

Adagio Medical has received FDA approval to expand its ventricular ablation trial. This development marks a significant step forward for the company's innovative cardiac treatment technology. The expanded trial will allow for further evaluation of the therapy's efficacy and safety in a larger patient population. Positive outcomes from this trial could pave the way for broader clinical adoption and eventual market approval, offering new hope for patients with complex heart conditions.